Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Change in Inventory: 2020-2024

Historic Change in Inventory for Xeris Biopharma Holdings (XERS) over the last 5 years, with Dec 2024 value amounting to $8.8 million.

  • Xeris Biopharma Holdings' Change in Inventory rose 289.79% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 161.31%. This contributed to the annual value of $8.8 million for FY2024, which is 40.68% down from last year.
  • As of FY2024, Xeris Biopharma Holdings' Change in Inventory stood at $8.8 million, which was down 40.68% from $14.8 million recorded in FY2023.
  • Over the past 5 years, Xeris Biopharma Holdings' Change in Inventory peaked at $14.8 million during FY2023, and registered a low of $5.1 million during FY2020.
  • Moreover, its 3-year median value for Change in Inventory was $8.8 million (2024), whereas its average is $10.4 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first spiked by 98.31% in 2023, then plummeted by 40.68% in 2024.
  • Over the past 5 years, Xeris Biopharma Holdings' Change in Inventory (Yearly) stood at $5.1 million in 2020, then skyrocketed by 44.23% to $7.4 million in 2021, then grew by 0.63% to $7.5 million in 2022, then soared by 98.31% to $14.8 million in 2023, then plummeted by 40.68% to $8.8 million in 2024.